Overview
Yi-fang Chang practices in Taiwan. Mr. Chang is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Essential Thrombocythemia, Head and Neck Squamous Cell Carcinoma (HNSCC), Blood Clots, and Myeloproliferative Neoplasms (MPN).
His clinical research consists of co-authoring 43 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Blood ClotsMr. Chang isExperienced. Learn about Blood Clots.
- Chronic Myelogenous Leukemia (CML)Mr. Chang isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Essential ThrombocythemiaMr. Chang isExperienced. Learn about Essential Thrombocythemia.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung CancerMr. Chang isExperienced. Learn about Lung Cancer.
- Myeloproliferative Neoplasms (MPN)Mr. Chang isExperienced. Learn about Myeloproliferative Neoplasms (MPN).